During the past decade, Morinaga Ueno Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Morinaga Ueno Clinic" are "Diabetic Gastroparesis" (1 trials), "Erosive Esophagitis" (1 trials), "Idiopathic Gastroparesis" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Morinaga Ueno Clinic" in a lesser frequency.

Most popular intervention types in "Morinaga Ueno Clinic" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Lansoprazole" (1 trials), "Oral antihyperglycemic medication (OAM)" (1 trials), "Placebo" (1 trials), "TAK-906 Maleate" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Morinaga Ueno Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Morinaga Ueno Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Morinaga Ueno Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Morinaga Ueno Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".